Información del producto
LEI401 is a drug that inhibits the Wnt/β-catenin signaling pathway. LEI401 has been shown to inhibit the growth of cancer cells in vitro and in animal models. It also shows efficacy against other types of cancers, such as leukemia and lymphoma, with possible applications for treatments of tumors. LEI401 is currently under investigation for its potential to treat Alzheimer's disease and Huntington's disease. In addition, LEI401 has been shown to have anthelmintic activity against nematodes (roundworms). The drug targets proteasomes in nematodes and causes premature protein degradation, leading to cell death.
Propiedades químicas
Consulta técnica sobre: 3D-BL178105 LEI401
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
